PAIGE POTTER: Open Payments
NPI 1508347147 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$374 in 13 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $174 · 2025 $374
Food & beverage: $374
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $157 |
| ABBVIE INC. | 2 | $47 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $43 |
| Lilly USA, LLC | 2 | $36 |
| Hologic Sales and Service, LLC | 1 | $24 |
| PFIZER INC. | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $20 |
Products named: AIRSUPRA, XIFAXAN, MOUNJARO, QULIPTA, APTIMA, PAXLOVID, UBRELVY, Ozempic.
Industry payments across CA — which companies pay providers there.
